Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia.

Chen, Kent T J; Gilabert-Oriol, Roger; Bally, Marcel B; Leung, Ada W Y

Chen, Kent T J; Gilabert-Oriol, Roger; Bally, Marcel B; Leung, Ada W Y.

Afiliação

Chen KTJ; Department of Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Gilabert-Oriol R; Department of Interdisciplinary Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Bally MB; Department of Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Leung AWY; Department of Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada. mbally@bccrc.ca.

Pharm Res ; 36(9): 125, 2019 Jun 24.

Article em En | MEDLINE | ID: mdl-31236772

Assuntos

Antineoplásicos/uso terapêutico; Leucemia Mieloide Aguda/terapia; Idoso; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Terapia Combinada; Portadores de Fármacos; Composição de Medicamentos; Humanos; Imunoterapia; Nanopartículas/química

Palavras-chave

acute myeloid leukemia; immunotherapy; liposomes; nanotechnology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antineoplásicos Limite: Aged / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google